Skip to content
10-Q

Quarterly Report

Contineum Therapeutics, Inc. CTNM

0001437749-25-024852

← back to feed
Filed
Aug 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 28.04M sh
Capex Q2 2025 · Jun 30, 2025 $91K
Capex Q2 2025 · Jun 30, 2024 $266K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$30.07M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$16.47M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $20.78M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $21.94M
Stockholders Equity Q2 2025 · Jun 30, 2025 $171.39M
Stockholders Equity Q2 2025 · Mar 31, 2025 $184.77M
Stockholders Equity Q2 2025 · Dec 31, 2024 $198.07M
Stockholders Equity Q2 2025 · Jun 30, 2024 $217.5M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$75.63M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$67.94M
Current Liabilities Q2 2025 · Jun 30, 2025 $7.21M
Current Liabilities Q2 2025 · Dec 31, 2024 $9.97M
Total Liabilities Q2 2025 · Jun 30, 2025 $11.5M
Total Liabilities Q2 2025 · Dec 31, 2024 $14.78M
Current Assets Q2 2025 · Jun 30, 2025 $176.84M
Current Assets Q2 2025 · Dec 31, 2024 $206.39M
Total Assets Q2 2025 · Jun 30, 2025 $182.89M
Total Assets Q2 2025 · Dec 31, 2024 $212.85M
Eps Basic Q2 2025 · Jun 30, 2025 −$0.62
Eps Basic Q2 2025 · Jun 30, 2025 −$1.24
Eps Basic Q2 2025 · Jun 30, 2024 −$0.39
Eps Basic Q2 2025 · Jun 30, 2024 −$1.35
Sga Expense Q2 2025 · Jun 30, 2025 $3.84M
Sga Expense Q2 2025 · Jun 30, 2025 $8.24M
Sga Expense Q2 2025 · Jun 30, 2024 $3.04M
Sga Expense Q2 2025 · Jun 30, 2024 $5.2M
Rd Expense Q2 2025 · Jun 30, 2025 $14.06M
Rd Expense Q2 2025 · Jun 30, 2025 $27.78M
Rd Expense Q2 2025 · Jun 30, 2024 $7.9M
Rd Expense Q2 2025 · Jun 30, 2024 $15.68M
Net Income Q2 2025 · Jun 30, 2025 −$16.04M
Net Income Q2 2025 · Jun 30, 2025 −$32.03M
Net Income Q2 2025 · Mar 31, 2025 −$15.99M
Net Income Q2 2025 · Jun 30, 2024 −$9.01M
Net Income Q2 2025 · Jun 30, 2024 −$17.43M
Net Income Q2 2025 · Mar 31, 2024 −$8.42M
Operating Income Q2 2025 · Jun 30, 2025 −$17.9M
Operating Income Q2 2025 · Jun 30, 2025 −$36.01M
Operating Income Q2 2025 · Jun 30, 2024 −$10.94M
Operating Income Q2 2025 · Jun 30, 2024 −$20.87M